OliX PharmaceuticalsI Financials
| 226950 Stock | 16,490 2,060 11.11% |
OliX |
Understanding current and past OliX PharmaceuticalsI Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of OliX PharmaceuticalsI's financial statements are interrelated, with each one affecting the others. For example, an increase in OliX PharmaceuticalsI's assets may result in an increase in income on the income statement.
Please note, the presentation of OliX PharmaceuticalsI's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OliX PharmaceuticalsI's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of OliX PharmaceuticalsI's management manipulating its earnings.
| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7226950004 |
| Business Address | 1014 Gwanggyo Ace |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.olixpharma.com |
| Phone | 82 3 1779 8400 |
You should never invest in OliX PharmaceuticalsI without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of OliX Stock, because this is throwing your money away. Analyzing the key information contained in OliX PharmaceuticalsI's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
OliX PharmaceuticalsI Key Financial Ratios
OliX PharmaceuticalsI's financial ratios allow both analysts and investors to convert raw data from OliX PharmaceuticalsI's financial statements into concise, actionable information that can be used to evaluate the performance of OliX PharmaceuticalsI over time and compare it to other companies across industries.| Return On Equity | -76.63 | |||
| Return On Asset | -0.16 | |||
| Number Of Employees | 67 | |||
| Beta | 0.99 | |||
| Z Score | 4.2 |
OliX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OliX PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare OliX PharmaceuticalsI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OliX PharmaceuticalsI competition to find correlations between indicators driving OliX PharmaceuticalsI's intrinsic value. More Info.OliX PharmaceuticalsInc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OliX PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OliX PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.OliX PharmaceuticalsInc Systematic Risk
OliX PharmaceuticalsI's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. OliX PharmaceuticalsI volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on OliX PharmaceuticalsInc correlated with the market. If Beta is less than 0 OliX PharmaceuticalsI generally moves in the opposite direction as compared to the market. If OliX PharmaceuticalsI Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one OliX PharmaceuticalsInc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of OliX PharmaceuticalsI is generally in the same direction as the market. If Beta > 1 OliX PharmaceuticalsI moves generally in the same direction as, but more than the movement of the benchmark.
OliX PharmaceuticalsI December 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of OliX PharmaceuticalsI help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OliX PharmaceuticalsInc. We use our internally-developed statistical techniques to arrive at the intrinsic value of OliX PharmaceuticalsInc based on widely used predictive technical indicators. In general, we focus on analyzing OliX Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OliX PharmaceuticalsI's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.14 | |||
| Information Ratio | 0.0203 | |||
| Maximum Drawdown | 41.85 | |||
| Value At Risk | (10.04) | |||
| Potential Upside | 12.77 |
Complementary Tools for OliX Stock analysis
When running OliX PharmaceuticalsI's price analysis, check to measure OliX PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OliX PharmaceuticalsI is operating at the current time. Most of OliX PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of OliX PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OliX PharmaceuticalsI's price. Additionally, you may evaluate how the addition of OliX PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |